ENDO PHARMACEUTICLS (NASDAQ:ENDP)
22.20
0.13 (0.58%)
| ENDO PHARMACEUTICLS (NASDAQ:ENDP) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $22.33 | 52 Week High | $26.14 | ||
| Open | $22.24 | 52 Week Low | $15.75 | ||
| Day High | $22.36 | P/E | 13.45 | ||
| Day Low | $22.17 | EPS | $1.65 | ||
| Volume | 546,950 | ||||
| More ENDP Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| IDEV | 8 | FRX | 5 |
| MRX | 4 | CEPH | 4 |
| AGN | 3 | MYL | 3 |
| ICE | 3 | KG | 3 |
| SEPR | 3 | YRCW | 3 |
| IMN | 2 | GOOG | 2 |
Entities who have mentioned ENDP
- UBS | View Related Stories »
- Scopia Capital | View Related Stories »
- Merriman Curhan Ford | View Related Stories »
- Goldman Sachs | View Related Stories »
- Wachovia | View Related Stories »
- Dividend | View Related Stories »
- Stifel Nicolaus | View Related Stories »
- D.E. Shaw | View Related Stories »
- Piper Jaffray | View Related Stories »
- Buckingham Research | View Related Stories »
- Deutsche Bank | View Related Stories »
- Collins Stewart | View Related Stories »
- Cowen & Co | View Related Stories »
- Notable Mergers and Acquisitions | View Related Stories »
- Soleil Securities | View Related Stories »
- After-Hours Movers | View Related Stories »
- Credit Suisse | View Related Stories »
- FDIC | View Related Stories »
- Raymond James | View Related Stories »
- Citi | View Related Stories »
- Morgan Stanley | View Related Stories »
- 13D | View Related Stories »
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
View All Major News StreetInsider.com Major News for ENDP
- Endo Pharma (ENDP) Posts Q3 EPS of $0.63, Misses By 1c; Guides
- Endo Pharmaceuticals (ENDP) Tops Q2 EPS by 6c; Reaffirms
- Endo Pharmaceuticals (ENDP) Reports Mixed Q1 Results
View All ReportsStreetInsider.com Reports on ENDP
- Endo Pharma (ENDP) Announces Settlement with LecTec Over Outstanding Patent Litigation
- Endo Pharma (ENDP) Posts Q3 EPS of $0.63, Misses By 1c; Guides
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- Endo Pharmaceuticals (ENDP) Receives Complete Response From FDA On FORTESTA
- Oppenheimer Upgrades Endo Pharmaceuticals (ENDP) to Outperform
View All Press ReleasesCompany Press Releases on ENDP
- Endo Pharmaceuticals and LecTec Settle Patent Dispute
- Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
- Endo Pharmaceuticals Gives Update on Regulatory Status of FORTESTA(TM)
- Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009
- Endo Pharmaceuticals Announces Expiration of Cash Tender Offer for Ledgemont PhaRMA(SM) Secured 16% Notes
StreetInsider Reports on ENDP by Category
View All BlogsBlogs on ENDP
- 12 Cheap Growth Companies
- Analyst upgrades, downgrades and initiations: AAPL, BAC, C, CMCSA, NOK, USB ...
- 11 Ache-free Investment Opportunities in Neuropathic Pain
- Six Additions to My Greenblatt-Style 'Magic Formula' List
- Three Recent Biotech Activist Wins by Carl Icahn
View All FilingsSEC Filings on ENDP
- Form 8-K ENDO PHARMACEUTICALS For: Nov 11
- Form 8-K ENDO PHARMACEUTICALS For: Nov 04
- Form 10-Q ENDO PHARMACEUTICALS For: Sep 30
- Form 8-K ENDO PHARMACEUTICALS For: Oct 29
- Form 8-K ENDO PHARMACEUTICALS For: Oct 16
Comments on ENDP
No comments are currently available.
